人營養類胡蘿蔔素的全球市場 (2022-2028年):各類型 (蝦青素、β-胡蘿蔔素)、用途 (營養補充品、功能性營養) 的規模、佔有率、成長分析、預測

Global Carotenoids In Human Nutrition Market Size, Share, Growth Analysis, By Type(Astaxanthin, Beta-Carotene), By Application(Dietary Supplements, Functional Nutrition) - Industry Forecast 2022-2028

出版日期: 2023年04月13日 | 出版商:

SkyQuest | 英文 221 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

人營養類胡蘿蔔素的市場規模，2021年是30億1,000萬美元，2022年是32億2,000萬美元，從2023年到2030年的預測期間中預計以7.1％的年複合成長率發展，2030年成長到59億8,000萬美元的規模成長。

由於天然色素和營養補充品的消費者需求高漲，市場預計大幅成長。類胡蘿蔔素是許多水果和蔬菜中包含的天然色素，有抗氧化作用。免疫功能的提高和降低慢性疾病的風險等，類胡蘿蔔素相關的健康效果的認識高漲，推動市場成長。

本報告提供全球人營養類胡蘿蔔素的市場調查，市場概要，市場的各種影響因素的分析，技術、革新趨勢，法律制度，市場規模的變化、預測，各種區分、各地區的明細，競爭情形，主要企業簡介等彙整資訊。

市場概要
市場規模
市場動態
促進因素
機會
阻礙因素
課題
主要市場洞察
技術分析
價格分析
供應鏈分析
價值鏈分析
市場生態系統
IP分析
貿易分析
Start-Ups分析
原料分析
革新矩陣
開發中產品的分析
宏觀經濟指標
主要投資分析
主要成功因素
競爭的程度
市場動態及預測
市場動態
促進因素
機會
阻礙因素
課題
法規情形
波特分析
未來阻礙相關Skyquest的特別洞察

全球人營養類胡蘿蔔素市場:各類型

市場概要
蝦青素
β胡蘿蔔素
葉黃素
茄紅素
角黃素
玉米黃質
其他

全球人營養類胡蘿蔔素市場:各用途

市場概要
營養補充品
功能性營養
運動營養
嬰兒營養
其他
全球人營養類胡蘿蔔素市場:各地區
市場概要
北美
美國
加拿大
歐洲
德國
西班牙
法國
英國
其他的歐洲地區
亞太地區
中國
印度
日本
韓國
其他的亞太地區
南美
巴西
其他南美國家
中東、非洲
GCC各國
南非
其他的中東、非洲地區
競爭情形
主要5家公司的比較
主要企業的市場上的地位
主要企業的採用策略
主要成功策略
市場上最近的活動
主要企業的市場佔有率
主要企業簡介
BASF S.E.
GSK,
Roche
Novo Nordisk
Koninklijke DSM N.V.
Givaudan Group
Dr. Reddy's Laboratories
Cipla
Sun Pharmaceutical

簡介目錄

Product Code: SQSG30I2032

Global Carotenoids in Human Nutrition Market size was valued at USD 3.01 billion in 2021 and is poised to grow from USD 3.22 billion in 2022 to USD 5.98 billion by 2030, growing at a CAGR of 7.1% in the forecast period (2023-2030).

The global carotenoids in human nutrition market is expected to experience significant growth due to the increasing consumer demand for natural colorants and dietary supplements. Carotenoids are natural pigments that are found in many fruits and vegetables, and are known for their antioxidant properties. They are commonly used in food, dietary supplements, and pharmaceuticals. The rising awareness of the health benefits associated with carotenoids, such as improved immune function and reduced risk of chronic diseases, is driving the market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of Carotenoids in Human Nutrition market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

The Global Carotenoids in Human Nutrition Market is segmented based on Type, Application, and Region. Based on the Type, the Global Carotenoids in Human Nutrition Market are segmented as Astaxanthin, Beta-Carotene, Lutein, Lycopene, Canthaxanthin, Zeaxanthin, and Others. Based on the Application, the Global Carotenoids in Human Nutrition Market is segmented as Dietary Supplements, Functional Nutrition, Sports Nutrition, and Infant Nutrition. Based on Region it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Driver

Dietary supplements in North America frequently incorporate synthetic carotenoids such as -carotene, -carotene, lutein, zeaxanthin, lycopene, and -cryptoxanthin. Nonetheless, there is an increasing demand for naturally sourced carotenoids in the pharmaceutical industry, and opportunities for growth in high-potential markets are expected to drive global demand for carotenoids. This highlights the need to explore natural sources of carotenoids for use in pharmaceutical applications.

Restrain

The production of carotenoids through chemical synthesis or plant extraction is facing challenges due to low yields, leading to high production costs. In addition, temporary border closures in some countries have restricted the export and import of non-essential products, which is exacerbating the hindrances to the growth of this industry.

Trend

The pharmaceutical and cosmetics industries are increasingly utilizing carotenoids as nutraceuticals due to the growing awareness of their health benefits. It is anticipated that there will be a rise in the use of synthetic sources of carotenoids in the coming years.